Is there a role for postremission therapy in older adults with acute myelogenous leukemia (AML)?
Rowe
J M
JM
Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Technion, Israel Institute of Technology, Haifa, Israel. rowe.jimmy.harvard.edu
D000367:Age Factors; D000368:Aged; D018572:Disease-Free Survival; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D011446:Prospective Studies; D012074:Remission Induction; D015996:Survival Rate